Improving Revenue Cycle in Healthcare Facilities in a Post-Pandemic World

May 25, 2021/6856 views / 0 Comments/in BLOG, Data Integrity, Denied Claims, healthcare, Patient Identification, Patient Outcomes, Revenue Cycle Management, Telehealth /by Matt Gibson

The pandemic hasn’t only been difficult for the healthcare sector in terms of the number of patients treated and the severity of symptoms. For the American healthcare system, it meant a huge loss of revenue for everyday treatments, as every available resource pivoted to caring for the patients affected by COVID. Those facilities that couldn’t pivot were left with no option but to close and file for bankruptcy as their income was hit. Some managed to survive by furloughing their staff or redeploying them to care for the large number of seriously ill patients which COVID produced. As a result, revenue cycle in healthcare facilities took a huge hit.

Some organizations, though, were luckier than others and were able to deploy remote triaging and virtual consultations by phone and video using the latest videoconferencing software – all of which can be bolstered by utilizing a touchless biometric patient identification platform such as RightPatient. This allowed them to continue to treat patients, and earn income, which softened the blow to their finances and helped both patients – who suffered no break in treatment – and staff – who were retained rather than furloughed.

Revenue cycle in healthcare facilities during the pandemic tanked, to put it mildly. Normal service dropped off a cliff and around three-quarters of healthcare providers had to put revenue cycle management in place, as well as ensuring employees could practice remotely and maintain effective social distancing when they did have to attend their workplace.

The return has started, remotely

Now that treatment cycles are returning to pre-pandemic levels in many places, the staff members are also returning to their usual roles. They are returning to treating their regular patients and making sure of their incoming revenue whilst minimizing the losses their facility may have suffered.

In order to optimize their abilities, staff members have learned how to use technology to help them assist patients remotely during the pandemic. This approach is likely to remain in place for those patients who are unable for any number of reasons to attend an in-person consultation.

One of the most popular ways to use tech in medicine is by organizing a remote consultation, by telephone or video call. This helps staff to find out quickly what ails their patient and can help them triage the patient more effectively, immediately. They can tell the caller at once whether they need to attend, offer an appointment if so and have all the notes from the call available when the patient comes in. If a referral is needed, the process can be started straight after the phone call, without waiting for an appointment or paperwork.

Of course, processes still need to be followed. Not only does that enhance patient safety, but it also embeds the familiar for both patient and healthcare employee. Sorting out the paperwork before the patient arrives is of prime importance, and means everyone will know what is going to happen and what they can expect to be billed or paid for. Staff should check whether there is an authorization for the service under the patient’s insurance and what the patient’s responsibility is regarding this. Ensuring everyone is aware of charges and can reconcile them quickly is better for the provider’s income levels too. Being organized allows accurate expenditure planning, which helps everyone balance incoming revenue against outgoing expected payments.

Communication is key for improving revenue cycle in healthcare

Face-to-face, by email, text, shared app, or phone: no matter how teams communicate, it is best that they do. Patients with comorbidities or multiple conditions need dovetailed treatment, a patient pathway across several providers, and it is best to schedule appointments logically. Scheduling several simple appointments across nearby providers in one day is a possibility to reduce travel headaches for the patient, although it may make it an expensive time when the bills come due. That also relies on the finance and revenue cycle team knowing that they are to bill a particular insurance company for a defined treatment to a named patient on a given date. Communication makes all of these processes simpler and can help provide the necessary paper or electronic trails to ensure timely billing, and therefore prompt payment. The notification to finance should come from the clinical team, as they are treating the patient. They also know exactly which procedure was undertaken and how, so are best placed to ensure the billing is correct.

An efficient billing cycle is one way to ensure reliable income, as everyone knows what is due to be paid, by whom, and when. It’s not just the medics and revenue billing team who have a part to play here either. Every healthcare professional who attends to the patient has a responsibility to produce documentation for their part in the patient’s care – all of this works towards optimizing revenue cycle management in healthcare facilities.

Technology can enhance revenue cycle in healthcare facilities

Accurate billing is essential when attempting to collect revenue. Billing the wrong patient, or a different insurance company, can delay payment and cause extra effort and paperwork for no gain. Correct patient identification at the start of the treatment cycle makes billing much simpler. A biometric touchless platform such as RightPatient can help eliminate patient misidentification and the nearly $5 million of denied claims which result.

It’s Time to Improve the Patient Experience as In-Person Medical Visits Are Back

May 24, 2021/7020 views / 0 Comments/in BLOG, Data Integrity, EHR, healthcare, Patient Data, Patient Experience, Patient Identification, Patient Outcomes, Patient Safety, Telehealth /by Matt Gibson

Now that lockdown is easing, in-person visits to medical facilities for non-urgent reasons can resume. Masks are being removed, people can come into closer contact than they could previously, and the routines of everyday life are returning. This is where hospitals can put into practice new ways of working which were adopted because of the pandemic and improve the patient experience.

RightPatient improves the patient experience

More virtual appointments to prevent waiting times and improve punctuality for those patients who do need to be seen in person. Telephone triaging so that the patient is routed to the correct specialist faster. Individual consultations rather than groups which may encourage patients to be more open about their ailment, or group sessions held remotely so patients who work better with a support network can still have that feeling of accountability. All of these, when used appropriately for the individual patient, can improve the patient experience, reduce patient safety incidents, and improve healthcare outcomes.

Virtual consultations may not be for everyone

Of course, a touchless biometric patient identification platform such as RightPatient can improve quality and safety in healthcare where it is used. As hospitals and other healthcare locations move towards dealing with higher numbers of routine patients again, anything which can simplify the process should be welcome. There is a significant backlog of routine procedures which need to be undertaken having been canceled in favor of treating COVID infected patients, so all the staff members are likely to be busy for some time to come. Some workers were furloughed, other facilities had departments closed and remaining staff diverted to caring for acutely ill patients. Now, they need to return to their more usual work, while picking up the pieces of disrupted patient treatment pathways and working to improve the patient experience.

Naturally, this had a knock-on effect on medical income, with the loss to hospitals estimated to be somewhere between $320 billion to $325 billion. Now that people are receiving vaccines at speed and the rate of infection is slowing, medical facilities can begin to work on regaining some of that lost income and treating those patients who may have chronic conditions or have developed one after overcoming COVID.

Normal, but not normal

Just because everything is opening up again doesn’t mean that everyone shouldn’t be alert to the potential for new variants of the virus. Like ‘flu and colds, the COVID virus mutates, and there is always the risk that the next outbreak could be just as virulent. Keeping social distancing, minimizing queuing, and ensuring adequate ventilation are practical ways to reduce risk to staff and patients. However, technology has a part to play too.

Improving-patient-experience-is-feasible-with-RightPatient

RightPatient has been improving the patient experience for several hospitals

Remote consultations save time, effort, the patient’s money, and improve the patient experience

Telehealth, the use of virtual or remote appointments rather than in-person consultations, has become popular for first consultations, initial triaging, counseling, and any discussion where actual hands-on physical examination is not required. For some people, it may be mentally less stressful to undertake healthcare appointments in this fashion. For others, it may be simpler and quicker, removing the need for time off work or lengthy journeys. Using telehealth the professional can easily work out which patients to call in for an in-person examination and who simply needs a new prescription or a referral to further care. Telehealth can take the form of a telephone call or video consultation, so most patients should be able to start their treatment pathway virtually. The reduced numbers of patients attending the facility will lower the likelihood of infection and reduce risk to staff and those patients who are clinically more vulnerable to the virus.

The public’s awareness of and engagement with healthcare staff has increased due to the pandemic. More people have been coming into contact with a wide variety of medical professionals as a result of the events of the last year. These people are not just those infected with the virus, they are members of the public who have struggled with loneliness and isolation, mental health issues, grief and loss, as well as those whose domestic arrangements were not suited to extended shelter-in-place requirements.

For many of these people, a remote solution is easier than an in-person visit. Actually leaving the house may be impossible for some, depending on their circumstances. It may be safer for them to remain at home, to have their medication delivered to them, and not to put their long-term health at risk by attending hospital in person. Hospital-acquired infections are a big risk to immunocompromised patients, and after a year of keeping themselves safe, they may be reticent about venturing out too far.

Touchless biometric patient identification solutions such as RightPatient can help healthcare providers ensure that they are treating accurate patients. Because RightPatient is biometric, patient identification is visually by camera rather than confirming answers to questions – it helps improve the patient experience during both virtual and in-person visits.

RightPatient can help healthcare providers treat their patients with less disruption and lower risk to the patients. The providers are still paid for their time and expertise, but the patient avoids an in-person visit unless an examination or procedure is indicated. That’s more convenient all around.

How to Improve Healthcare Outcomes and Reduce Readmission Rates

May 23, 2021/6749 views / 0 Comments/in BLOG, Data Integrity, Duplicate Medical Records, EHR, healthcare, Medical Identity Theft, Medical Record Mix-ups, Patient Identification, Patient Outcomes, Patient Safety /by Matt Gibson

Improving a patient’s outcome (for instance, their quality of life or life expectancy) is obviously the prime reason for treating them. Patients approach a medical professional with the hope of ‘being cured’ of whatever ails them, whether that’s by being prescribed medication to ease symptoms or having an operation or procedure to relieve pain or remove or transplant a body part to offer a better quality of life. When they are paying for their treatment, they have every right to expect that their life is better afterward. Hospitals that do not achieve the required levels of treatment outcome are routinely penalized, thus, they need to improve healthcare outcomes. These levels are measured by readmission rates. On average, over 2,500 hospitals are likely to be penalized because of their monthly readmission rates, even though the pandemic will have increased the chances of some patients having to be readmitted.

Improve healthcare outcomes with an effective patient identification platform

However, there are some very simple ways in which hospitals can improve healthcare outcomes and reduce readmission rates.

Identify your patient. Continue to identify your patient.

Correct patient identification is key. Ensuring that staff members are treating the right patient for the right ailment is, perhaps, needless to say, the best way to improve healthcare outcomes. Getting identification wrong can lead to any number of issues, from unnecessary operations or incorrect scans to potentially dangerous prescription medication being offered.

The best way of ensuring correct patient identification is by using a touchless biometric patient identification platform such as RightPatient. It helps improve healthcare outcomes, ensures timely sharing of appropriate information with other professionals, and ultimately helps lower the chances of a patient safety incident.

The data may be on the screen, and may well be correct. But front desk staff, nurses, medics, and others are only going to know this for sure if they use such a solution. The available data is also likely to show previous admissions, incidents that the patient may have been involved in, allergies, vital statistics, next of kin, and areas of concern for the patient’s health.

Many hospitals undertake patient surveys to help them improve patient care, and this option can be offered as a patient reaches discharge date, if appropriate.

Goals, KPIs, outcomes, HSMRs – whatever you call them, they help improve healthcare outcomes.

Improving the patient’s experience of their stay in the hospital will also improve their view of how well they were treated. A positive outlook has been shown to raise recovery rates. Plus, helping patients recover makes staff feel better too. Making a good outcome a key goal of the organization and the staff will help both sides. Suggesting a reduction in incidents from the previous year is a friendly way to ask for an improvement in figures, whilst still recognizing that employees are human and can make mistakes.

RightPatient identifies patient records accurately

No matter how good the records, unnecessary scans can be requested and patient information can be incorrectly recorded. It happens. If the patient’s identity can be verified accurately, then mistakes can be avoided.

Sharing is caring.

Sharing information with other caregivers can also improve healthcare outcomes and provide healthcare professionals with a rounded picture of the person they are treating. Not all patients will be happy with this option, but for primary care doctors, knowing where else their patients have already been treated is of great benefit when referring them to other specialties. Many people have to see a different physician for every ailment, and joined up care can make things much easier. When someone with a chronic condition ends up in the ER, a shared electronic health record allows everyone to know what medication the patient has already been prescribed and even whether certain common treatments have already been attempted.

CMS, therefore, requires healthcare providers to use CoP electronic notifications to let other named physicians know that they have a patient in their care. These notifications also alert others in the chain about patient discharge or transfer, which is important for ongoing care – using RightPatient can help with that. RightPatient also aims to prevent duplicate medical records, so acting against medical identity theft. All of this helps CMS compliance, which is good news for a facility’s finances, as fines for CMS breaches can be crippling after a while.

Contact us for more information on how RightPatient can help your facility and your patients stay safer from medical mix-ups and online impersonation by using our biometric patient identity management system.

Professional Patients Are One of the Overlooked Issues in Modern Clinical Trials

May 7, 2021/6088 views / 0 Comments/in BLOG, Clinical Trials, Data Integrity, Patient Data, Patient Identification, Patient Outcomes, Professional Patients, Research /by Matt Gibson

Clinical trials and professional patients – we’ve been talking about them for quite some time now and how fraudsters are one of the overlooked issues in modern clinical trials. While most enrolled patients are strongly vetted and their backgrounds are thoroughly checked, we’ve already seen many times that the information they provide isn’t always accurate and how these fraudsters slip through the cracks and make it into the trials. However, we’ve got more stories that demonstrate how professional patients exist in trials.

That being said, let’s take a look at a few more studies regarding professional patients and how ensuring positive patient identification can prevent duplicate test subjects in clinical trials.

Modern clinical trials are vulnerable to professional patients.

Stories from an expert about one of the critical issues in modern clinical trials

COO of Verified Clinical Trials, Kerri Weingard, stated that out of all the patients that apply to participate in U.S. trials, those who falsify information or violate criteria range between 14% – 25%.

How do they qualify?

Most of these fraudulent applicants’ actions are quite similar to those of professional patients. According to Ms. Weingard, a few of these individuals enroll in studies for specific diseases and even tamper with their medical history to participate in other trials either subsequently or simultaneously. Some claim that they have conditions in one trial, and they don’t have them in others! Quite a simple example would be a person who enrolls in a trial for heart disease and says that they have the condition. After enrolling successfully and completing the trial, they will alter their medical history and enroll in another study claiming that they have no medical conditions.

Ms. Weingard also says that this is most common with CNS (central nervous system) trials. For instance, diseases such as panic disorder, anxiety, schizophrenia, bipolar disorder, and depression cannot be detected objectively – research teams have to rely on the symptoms reported or demonstrated by the patients. Professional patients take advantage of this and exaggerate or falsify their symptoms to enroll in the trial. Moreover, as many of them are in it for the money, they go to other trials and state that they don’t have such symptoms. All in all, their symptoms are dependent on the requirements of the trial and they have the ability to pull off the deception in many cases.

More numbers that show duplicate study subjects

Ms. Weingard also presented a study at the American Society of Clinical Psychopharmacology meeting – it focused on professional patients, was conducted for three years, and included 113 CNS trials. The total population was exactly 10,092 individuals and there were 498 inclusion or exclusion protocol violations, out of which 91 violated the washout period, 45 tried to qualify for an entirely different study at the same site and 25 at other sites, and 42 were red-flagged for trying to “dual enroll” in more than one study simultaneously.

Prevent-duplicate-test-subjects-effectively-with-RightPatient

Eliminate the participation of professional patients in clinical trials.

One thing is pretty clear – professional study subjects are one of the crucial issues in modern clinical trials, and a robust solution is needed to prevent them. One of the feasible ways is ensuring accurate patient identification with RightPatient – more on that later.

Another study states professional patients are a headache!

Dr. Thomas Shiovitz and his team conducted a study to determine the magnitude of the “professional patient” issue, and its title uses humor to express that professional patients are a headache in migraine trials.

Out of 2192 subjects who applied for the trials, around 19% attempted to register in a different site within 18 months. From this group, 24% of the subjects attempted to enroll in a different migraine trial and the rest of them (76%) tried to enroll in studies involving schizophrenia, depression, or even as healthy test subjects.

While many agree that some professional patients are dangerous, they argue that others are naive and don’t know the rules and regulations about participating in such trials. For instance, they’re provided with endless pages of terms and conditions, and many of them don’t even read the entire document before they sign up. As a result, they don’t know how they might affect other trials if they enroll in the subsequent ones consecutively or simultaneously. This is perhaps one of the reasons why professional patients are one of the ignored issues in modern clinical trials.

However, regardless of the different perspectives, professional study subjects do harm the efficacy of clinical trials and might cause them to be halted, delayed, or even prevent them from proceeding to the subsequent phases because research results are skewed and contain inaccurate information.

RightPatient prevents one of the critical issues of modern clinical trials

The participation of professional patients in clinical trials must be prevented at all costs – something our touchless patient identification platform can achieve efficiently.

RightPatient is the definitive patient identification platform used by responsible U.S. healthcare providers – it red flags fraudsters when they attempt to access care unlawfully. The platform can prevent professional patients in clinical trials as well. A patient won’t be able to enroll in the same trial twice, and if the information is shared across sites, they will be red-flagged when they try to enroll in the other sites.

Contact us now to learn more about how RightPatient can help protect the integrity of your trials effectively and efficiently.

When it Comes to Clinical Trial Challenges, Professional Patients are a Real Headache

May 6, 2021/6294 views / 0 Comments/in BLOG, Clinical Trials, Data Integrity, Patient Data, Patient Identification, Patient Outcomes, Patient Safety, Professional Patients, Research /by Matt Gibson

“Professional patients”, “duplicate test subjects”, whichever term you want to give them, are exceptionally dangerous and are one of the understated clinical trial challenges. Not only are they a danger to themselves, but they also put other patients in the trial at risk. Moreover, their involvement threatens the integrity of the trial(s) – research results are skewed significantly and that can cause effective medicine to be unapproved by regulatory bodies, generating billions in losses.

RightPatient protects the integrity of clinical trials by preventing professional patients.

If you’ve been following our latest series of blog posts closely, you’d know what we’re talking about. Even if you’re not, that’s not a problem, because we’ll be covering more on professional patients in this article. Let’s take a closer look at how they get into the trials, some stats that show how common these duplicate subjects are, how helping them has become a job, and how they can be prevented from trials with positive patient identification using RightPatient.

Just another tale that shows one of the overlooked clinical trial challenges

In a previous article, we’ve talked about different tales of professional patients in clinical trials, why it’s difficult to detect them in specific cases, and how being vigilant might help in rare cases.

A PI who dug deeper after experiencing professional patients firsthand

The gist of it is that in the case of some trials, it’s virtually impossible to detect the severity of the conditions via objective medical tests. As a result, research teams have to rely on self-reporting of the symptoms, and in some cases, these reports are exaggerated by professional patients. A PI (principal investigator) even witnessed that a professional patient participated in around seven trials in twelve months! Another PI remained vigilant and noticed that the patients lied by looking at their medical records – let’s continue from this one.

A study on the involvement of professional patients in clinical trials was conducted by Eric Devine, Ph.D., and fellow researchers. Unfortunately, the results were quite frightening and far worse than imagined – something every sponsor, CRO, and PI must know about.

Some unnerving stats about professional patients

A whopping 75% of individuals falsified information just to participate in clinical trials, and they were involved in two or more studies just in a single year. The misinformation was regarding their health, medications, and the symptoms they faced. For instance, around 33% of them concealed medical problems, 20% concealed recreational drug use, whereas 28% concealed prescribed medications. That’s not all they uncovered – 14% of the sample falsified about having the required condition(s) whereas 25% of them overstated their symptoms to be a part of the trial(s).

RightPatient-prevents-one-of-the-overlooked-clinical-trial-challenges-professional-patients

Ensure accurate patient identification and prevent professional patients in clinical trials now.

Helping others get into trials using deceitful tactics is a profession now

A crucial discovery Dr. Devine and his team made was finding the existence of a research expert who specializes in helping professional patients get into clinical trials. This “kingpin” researched and attempted to get into the study that consisted of Dr. Devine and the team because the payment was quite high. After gaining knowledge about the trial and the right answers to the questions, the individual charged others $40 to share what they needed to say and do to get into the trials.

Moreover, some individuals take up clinical trial enrollment as a profession and even maintain sites that have relevant information such as trial locations, study criteria, enrollment status, and so on. In those forums, they casually talk about how professional patients can get into clinical trials, according to Dr. Devine. In fact, organizations that check for deception are flagged by the site’s moderators, and also advise which clinical trials to skip if the patients want to enroll in a way that violates study criteria.

Professional patients are one of the lesser-known clinical trial challenges

This is just one of the many stories of professional patients – there are far too many of these duplicate test subjects. While some of these bad actors are discovered, others, unfortunately, make it through the trials undetected, something that is far more dangerous.

As mentioned at the beginning, not only does the presence of these bad actors put their safety in jeopardy, but it also threatens the integrity of the trials they participate in, leading to skewed results, halted or canceled trials, and billions in losses.

A potential solution to prevent duplicate study subjects

In a nutshell, professional patients must be prevented from participating. One of the most ideal ways to do so is by creating a centralized identity clearinghouse for clinical trial patients and ensure that the duplicate subjects are red-flagged whenever they try to enroll in a trial.

Fortunately, RightPatient can help with that. A touchless biometric patient identification platform used by several leading U.S. healthcare providers, RightPatient has the experience and capabilities to prevent professional patients in clinical trials.

Contact us now to know how we can help you protect the integrity of your clinical trials and prevent delays in approvals by eliminating a crucial problem – saving millions in the process and improving the efficacy of your studies.

Duplicate Subjects in Clinical Trials Are an Overlooked Pain Point – But They Can Be Stopped

May 5, 2021/6549 views / 0 Comments/in BLOG, Clinical Trials, Data Integrity, Patient Data, Patient Identification, Patient Safety, Professional Patients, Research /by Matt Gibson

We’ve been talking about duplicate subjects in clinical trials for quite some time now. That’s because they continue to exist in significant numbers, and, contrary to popular belief, these individuals DO hamper clinical trials in one way or another. While the impact on different clinical trials varies due to their involvement, the worst-case scenario is that the affected trial shuts down due to skewed research outcomes. As a result, promising medicine, medical procedure(s), or device(s) don’t see the light of day due to these fraudsters. That being said, let’s take a look at more real-life cases of professional patients and how a robust patient identity management platform can prevent their participation in clinical trials.

Prevent professional patients in clinical trials with RightPatient.

A few more cases of duplicate subjects in clinical trials

While we’ve seen a few cases where professional patients participated in clinical trials for the money or the free treatment involved, let’s take a look at a different case that shows why it is difficult to detect these fraudulent participants during enrollment – the case of patient Z.

Exaggerated, self-reported conditions lead to duplicate subjects in clinical trials

Those who are familiar with clinical trials know that potential study subjects or patients are vetted thoroughly before enrollment. For those who don’t know, in a nutshell, background checks are conducted, their physical conditions are screened to identify whether they are ideal for the trial via various medical tests, and interviews are conducted to identify any unwanted traits.

While these tests usually do identify any anomalies, they cannot identify conditions such as depression, anxiety, and even chronic pain, among other relevant diseases. Unfortunately, there are no objective medical tests (as of yet) that can determine whether a patient has any of the aforementioned conditions or not, only self-report screening instruments. As a result, exaggeration by professional patients regarding their condition(s) can get them enrolled in clinical trials, and that’s exactly the story of patient Z.

According to Dr. Thomas Shiovitz, he saw the peculiar case of a duplicate subject who actually went to seven sites within 12 months! Dr. Shiovitz states that he detected the patient in seven trials – however, the patient may have gone to more sites without being detected. Unfortunately, some of these studies were being conducted simultaneously, thus, the patient adversely affected most of their results.

When finally caught regarding his nefarious activities, the patient simply exclaimed “You caught me!”

Duplicate-test-subjects-in-clinical-trials-are-preventable

RightPatient prevents duplicate test subjects in clinical trials.

Some cases might be caught if the PIs remain vigilant

According to Eric Devine, Ph.D., he had somewhat of a similar experience. While conducting clinical trials or when talking to the patients, he witnessed a number of them who kept lying about one thing or another related to their medical conditions or identities. How did Dr. Devine detect the lies? It’s quite simple – he glanced at their medical records. There were even cases where he would recall a professional patient who came in with a different identity earlier – they were just desperate to participate in the trial. And this was not an isolated incident, Dr. Devine witnessed that many people utilized the same tactics to get into one of the clinical trials. This is exactly why we keep saying that duplicate subjects in clinical trials still exist, and in considerable numbers.

Therefore, after finding these fraudulent individuals, Dr. Devine tried to ensure that no more duplicate subjects were involved in his trials as they not only invite danger for themselves but also threaten the integrity of the trials.

Thankfully, RightPatient can remove the burden of detecting professional patients in clinical trials manually for Dr. Devine and for anyone who wants to ensure the efficacy of their clinical trials.

RightPatient prevents duplicate subjects in clinical trials

RightPatient has been helping leading U.S. healthcare providers prevent scammers from assuming their patients’ identities. It is a touchless biometric patient identification platform that prevents medical identity theft within healthcare facilities and at any touchpoint across the care continuum.

RightPatient identifies patients using their photos, and during enrollment, attaches them to their medical records. For subsequent visits, patients only need to look at the camera – RightPatient locates the accurate medical record after searching for a match.

Since it’s already tried and tested to prevent fraudulent individuals, it can do the same for clinical trials as well and prevent professional patients in clinical trials – saving them millions, ensuring the efficacy of the studies, and ensuring the safety of the subjects involved.

Professional Patients Are One of the Overlooked Clinical Trial Issues – More Examples

May 3, 2021/5923 views / 0 Comments/in BLOG, Clinical Trials, Data Integrity, Patient Data, Patient Identification, Patient Safety, Professional Patients, Research /by Matt Gibson

If you google the term “clinical trials” right now, you’ll see that virtually everyone is talking about them and are extremely interested in the topic. That’s because the pandemic has thrust the topic into the limelight, leading to even the average person talking about clinical trials. While most of the world is interested in clinical trials to learn about the vaccines that can combat the infamous virus, we’re here to talk about the efficacy and integrity of such studies. We’ve already covered how and why “professional patients” or “professional study subjects” are one of the less-discussed clinical trial issues. Today, let’s explore a few more real-life cases that support our claim and how effective patient identity management with RightPatient can prevent the participation of professional patients.

Professional patients in clinical trials are one of the less-discussed issues.

Some examples to confirm professional patients are one of the hidden clinical trial issues

We’ve already talked about a case of a professional patient who falsified their information and participated in a few clinical trials. While the patient was in it for the money, let’s take a look at some other real-life cases.

A tale of lies

Patient Y had also participated in multiple clinical trials – three, to be precise, in a span of five years. According to her, these trials are short-term opportunities, and she turns down the ones that involve testing unproven drugs on her. The initial trial she participated in involved the use of a certain “botulinum toxin”, and while there wasn’t any payment involved, she got the treatment for free.

The next trial patient Y participated in was about the study of the same toxin, and the research team took her blood sample, conducted an ECG, as well as other tests. This time, she did receive financial benefits – one of the incentives she searches for in trials. However, she provided incorrect information this time around – she decreased her age as well as lied when asked if she got Botox earlier or not (she did receive it in the first trial). She chose to get into the trial because she was getting paid and because she was getting free Botox.

One glaring issue here is that even though the officials could have easily checked patient Y’s documents to verify her age, they didn’t, and she got to participate in the trial. This shows that not everyone who signs up as a participant is vetted thoroughly, which is why a robust patient identification solution is required – more on that later. Moreover, even though these professional patients are falsifying information to get into the trials, many of them believe that they are contributing to the medical community by being participants. Unfortunately, that is far from the truth, as they are part of one of the overlooked but crucial clinical trial issues that threaten the integrity of the studies.

RightPatient-prevents-duplitcate-study-subjects-in-clinical-trials

Are you preventing professional patients from your clinical trials?

Even regular test subjects know a few professional patients!

This case is different, as the patient involved, Z, never used any unlawful means to participate in trials, and even though he participated in some trials, he did so by complying with the rules and regulations.

However, patient Z did meet a number of patients who used misinformation and other means to participate in the trials, and according to him, they believe that the rules do not apply to them.

While patient Z participated for the financial benefits as well as helping advance medicine, he complied with all the rules and regulations. He used the compensation he received to pay off debts as well as support himself for around ten years – one of the trials that focused on Alzheimer’s paid him $31,000.

Moreover, as his grandmother has Alzheimer’s, patient Z feels that by participating in clinical trials to advance medicine that might be of use to her one day, he’s helping her.

“Professional patients” continue to be one of the overlooked clinical trial issues

As the above examples show, “professional patients”, “professional study subjects”, or “duplicate subjects”, whichever term use, still exist in clinical trials. They falsify information such as their age, identity, medical history, etc. to enroll in multiple trials simultaneously or consecutively. Doing so not only hampers their health and safety, but the safety of the other patients involved in the trials.

To make matters worse, their involvement skews the overall results of the research, leading to delaying the trials or even shutting them down due to undesirable but inaccurate information. Professional patients cause billions of dollars in losses, can lead to delayed approvals from regulatory agencies, and lead to wasted years of effort from sponsors, research teams, and CROs. These individuals must be eliminated from clinical trials right from the start – RightPatient can help with that.

Use RightPatient to prevent one of the overlooked clinical trial issues

RightPatient is a tried and tested solution in the U.S. – several healthcare providers are protecting millions of patients with it. It is a touchless biometric patient identification platform that uses patients’ photos to identify them accurately across the care continuum, and the same concept can be used for clinical trials.

RightPatient can prevent the participation of professional patients in clinical trials by red-flagging individuals attempting to participate in either multiple trials or at different sites of the same trial. It helps improve the efficacy of clinical trials, remove any unwanted individuals that can skew the overall results, and protect the integrity of these trials.

Contact us now to learn how we can help protect your clinical trials from skewed results with our robust patient identification solution.

The Professional Patient Problem Still Exists in Clinical Trials – Are You Preventing Them?

May 2, 2021/5302 views / 0 Comments/in BLOG, Clinical Trials, Data Integrity, Patient Identification, Professional Patients, Research /by Matt Gibson

We’ve been talking about clinical trials for some time now. Usually, we talk about how integral these studies are for discovering new drugs, devices, or treatments, and how their outcomes affect all our lives as well as healthcare in general. However, today we are focused on one of the overlooked issues – the professional patient problem, and how the long-standing issue continues to skew overall results.

That being said, let’s take a look at a real-life case of a professional patient that participated in multiple clinical trials, how their involvement and actions can hamper trials and cause billions in losses, and how a patient identity verification platform like RightPatient can help prevent their participation.

RightPatient can prevent professional patients in clinical trials.

The professional patient problem is very real – a recent example

A case that occurred in 2019 in Louisiana

At the end of 2019, patient X had signed up for a clinical study for asthma. While she was accepted into the trial like most of the individuals that volunteered for it, she had falsified some of her information to make herself appear eligible for the trial.

There was a prerequisite stating that the subjects shouldn’t have had a certain steroid within the past two to three weeks. However, patient X did take it only a few days before signing up for the trial, and when she was asked, she flat-out denied taking it, as per Medscape Medical news. Unfortunately, she did make it into the trial, and her statement regarding her use of the steroid wasn’t verified.

However, that was just one clinical trial patient X participated in – there’s more. Otherwise, this wouldn’t have been an example of the professional patient problem!

Same professional patient, different study

Patient X participated in an entirely different study on nasal polyps, and in this case, she once again provided misleading information. While the trial focused on reducing nasal polyps using a certain spray, patient X was already using the same medication, but she informed the officials that she wasn’t. The study compensated her handsomely, which is why she was tempted to falsify information.

But what did the officials do to verify her information?

They requested a note from her physician, checked her driver’s license, required access to her patient portal, and viewed photos of her medications, among other things. Even then, they couldn’t detect the fact that she falsified information to sign up for the clinical trial.

Professional patients skew overall results and delay effective trials

The tale of patient X is not a rare incident, unfortunately. These cases are examples of the professional patient problem, and they occur too often to be ignored. The participation of these individuals is a significant blockage to carrying out clinical trials effectively, and more often than not, these cases are discovered only when it’s too late. Their involvement in the trials affects data significantly and might cause even promising drugs to be delayed or even announced to be ineffective. Not only does their participation cause promising drugs to not see the light of day, but it also causes much-needed breakthroughs in medicine to be delayed. These are the consequences of professional patients falsifying data, participating in multiple trials simultaneously or consecutively, and faking results, and might cause trials to not proceed to the subsequent phase(s). As a result, the participation of professional patients, or “professional study subjects”, must be eliminated.

Fortunately, professional patients in clinical trials can be prevented with RightPatient.

RightPatient helps combat the professional patient problem

A touchless biometric patient identification platform, RightPatient has been helping responsible healthcare providers prevent scammers from using healthcare services within their facilities. The platform identifies patients using their photos that are taken during registration and prevents fraudsters from assuming the identities of registered patients – it can do the same for clinical trials too.

RightPatient can help maintain a database of the registered patients in clinical trials at multiple sites, and whenever a fraudster or these professional patients try to sign up, the platform can red-flag them – saving billions, protecting the integrity of your trials, and preventing delays.

Use RightPatient now to see how it can ensure that your investments are protected and improve the efficacy of your clinical trial(s).

4 Common Challenges in Clinical Trials – How Are You Addressing Them?

April 21, 2021/8410 views / 4 Comments/in BLOG, Clinical Trials, Data Integrity, Patient Identification, Patient Matching, Professional Patients, Research /by Matt Gibson

We’ve talked at length about the challenges in hospitals, health systems, telehealth, and other aspects of the U.S. healthcare system. Today, let’s take a step back and look at challenges in clinical trials – invaluable studies without which there would be no advances in healthcare.

Preventing professional patients is an overlooked issue in clinical trials.

Clinical trials in a nutshell

Clinical trials have been around since ancient times. In fact, the first clinical trial can be traced back to biblical times – in 500 B.C.! Since then, there have been many changes and updates to how these trials are carried out as well as standards that have to be followed to ensure they are ethical.

Clinical trials are conducted to develop drugs, devices, or procedures that can improve human health. These trials mainly help identify whether the drugs are safe, have any side effects, and can be used by the general population.

While clinical trials used to be a very niche topic, its popularity skyrocketed due to the pandemic. Since the novel virus hit the world, virtually everyone has been asking the same question – when will there be a vaccine? Unfortunately, everyone skips over the challenges in clinical trials and they aren’t discussed as much as the vaccine itself. However, that’s exactly what we’ll look at today – some common challenges faced by organizations to carry out these complex, expensive trials.

4 common challenges in clinical trials

Clinical trials are not at all easy – they’re quite complex, lengthy, and are required to follow several rules and regulations to ensure compliance with different standards. Before starting a clinical trial and while running it, organizations face a number of challenges.

Slower patient recruitment than required

One of the biggest challenges is faced just before starting clinical trials, and it’s all about patient recruitment. Moreover, this is the stage that often determines whether the clinical trial will successfully commence or not as around 80% of these studies are either halted or even closed due to low patient recruitment. One of the reasons for this is the specific requirements of the trial. For instance, the trial requires patients to have a particular condition, but patients have other conditions as well which might lead to complications – finding the right patients proves to be quite a challenge indeed.

RightPatient-addresses-a-crucial-challenge-in-clinical-trials

RightPatient addresses one of the overlooked clinical trial challenges – preventing professional patients.

One way many sponsors deal with this is by setting realistic expectations and assuming the fact that not all of their sites will attract the desired number of patients. Another way sponsors tackle the challenge is by outsourcing recruitment since there are several organizations available that specialize in doing so.

Compliance with several rules and regulations

Overcoming the patient recruitment challenge is just the beginning as there’s another herculean task. Ensuring compliance with the rules and regulations has to be ensured throughout the duration of the trial, as it cannot be completed successfully unless the trial conforms to the rules and regulations to a T.

Since trials are full of complex activities, involve human subjects, untested drugs, devices, and procedures, ensuring compliance becomes mandatory to ensure patient safety as well as maintaining ethics of the trials. Usually, institutional review boards (IRBs) have to approve the processes, and that can be time-consuming as there are many factors to consider, which often create a bottleneck.

Managing multiple sites

While clinical trials usually occur over multiple sites to involve diverse patients, more sites mean more vendors, procedures, diverse compliance requirements, and coordination efforts, leading to more complexities down the line.

Creating a robust policy of how to deal with multiple sites and coordinate with one another is one of the only ways forward. Moreover, ensuring accurate patient records and properly managing patients is an absolute must to prevent mix-ups, inconsistencies, and ensure compliance.

Preventing professional patients

Professional patients, or duplicate subjects, are an overlooked but significant issue that hampers clinical trials and threatens the integrity of the trials they participate in. Professional patients sign up for multiple trials either simultaneously or consecutively, which seriously affects the clinical trials. They can even lead to skewing overall data which might render promising drugs unusable since the data shows that the drugs are not effective enough.

Not only do professional patients harm themselves, but they cause billions of dollars in losses or delays in approvals from pharmaceutical regulatory agencies. As a result, preventing professional patients is a must – something which RightPatient can help with.

RightPatient is a leading touchless biometric patient identification platform that ensures patients are accurately identified across the care continuum – several hospitals and health systems are already using it. Fortunately, it can prevent professional patients in clinical trials as well by validating that the patients’ identities and checking whether they are currently participating in other active trials or not. Not only can RightPatient help reduce significant losses, but it also helps protect the integrity of clinical trials – reducing errors and preventing professional patients from participating.

Senators Focusing on Improved EHR Data Shows the Importance of Patient Identification

March 2, 2021/7954 views / 2 Comments/in BLOG, Data Integrity, EHR, healthcare, Patient Data, Patient Identification, Patient Outcomes, Patient Safety /by Matt Gibson

Unfortunately, even now, many believe that patient misidentification is not a significant issue within the US healthcare system. Even many healthcare providers don’t think of it as a huge problem. They fail to acknowledge that patient misidentification corrupts EHR data significantly, leads to patient record mix-ups, is one of the causes of wrong medical procedures, causes avoidable medical errors, and more.

Let’s break down why they are wrong and how patient misidentification is a huge issue by observing what others are doing to solve it and how RightPatient is helping ensure positive patient identification.

Patient misidentification is a huge deal – corrupting EHR data is just one of its consequences

A crucial factor that can lead to better patient safety within hospitals, according to the Joint Commission’s National Patient Safety Goals for 2021, is by identifying patients accurately. That’s precisely why it has listed improving patient identification on the top of its list. Each year, the Joint Commission releases goals based on research that they believe will enhance patient safety. Each year, patient identification improvement is always one of the many goals, sometimes even topping the list (just like this year).

There are many healthcare organizations and associations such as AHIMA (The American Health Information Management Association) and CHIME (The College of Healthcare Information Management Executives) that focus on patient misidentification, its consequences (EHR data corruption, patient safety issues, detrimental healthcare outcomes), and the need for accurate patient identification.

Even last year, many organizations came together and formed a coalition called “Patient ID Now” for a national patient identifier. Unfortunately, there is very little progress in that area (as of now), and if the past tells us something, then the UPI (unique patient identifier) is still far from reality. Many organizations, healthcare experts, and officials urge the government to lift the ban on creating a state-funded UPI. Unfortunately, the ban has been in effect for more than two decades due to “privacy concerns”.

However, while all of that is occurring, patient misidentification is still thriving and causing issues such as duplicate medical records, corrupting EHR data, hampering patient safety, causing avoidable medical errors, and more. Fortunately, more people are identifying how big of a problem it is.

Patient misidentification is an issue significant enough to bring senators from different parties together. An effort taken by bipartisan senators is focused on improving patient record matching in hospitals and health systems, something that they believe is crucial for vaccine distribution as well.

Called the “Patient Matching Improvement Act”, it aims to provide vaccination sites, hospitals, and testing labs access to the US Postal Service’s address-formatting tool for improving patient record linkages. They believe that this will help contact tracing efforts and track community spread more accurately.

After the pandemic, it will also help improve EHR data within hospitals and health systems as they believe it will help improve patient identification. But will it be enough on its own, if it ever leaves the Senate health committee? What are responsible caregivers doing now to prevent patient misidentification?

RightPatient effectively prevents data corruption

While there are several solutions available, the most feasible one, given the pandemic, is RightPatient. It is a touchless biometric patient identification platform that is the choice of responsible healthcare providers. Since it is touchless, it doesn’t create infection control issues for healthcare providers – improving patient safety and ensuring hygiene.

It enhances patient safety, prevents medical identity theft in real-time, ensures that patients are identified at any touchpoint across the care continuum, and is even ideal for telehealth sessions.

However, if the Patient Matching Improvement Act is introduced, RightPatient can augment its effectiveness further, as it is a tried and tested platform used by responsible caregivers – are you one of them?